Literature DB >> 2504875

Strain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (E mu)-myc transgenic mice.

K Yukawa1, H Kikutani, T Inomoto, M Uehira, S H Bin, K Akagi, K Yamamura, T Kishimoto.   

Abstract

The transgenic mice were produced by injecting eggs of B6 and C3H/HeJ mice with the human E mu-myc gene. Preferential development of B lymphomas was observed in the B6 transgenic mice, whereas the C3H/HeJ transgenic mice developed mostly T lymphomas. The phenotypic activation of B lineage cells but not of T lineage cells was detected in the prelymphomatous transgenic mice of both strains. The transgene was similarly expressed in B and T cells of the transgenic mice of both strains. These results suggest that a high incidence of T lymphomas in the C3H/HeJ transgenic mice may not be due to the preferential activation of or the preferential E mu-myc expression in T lymphocytes. When the bone marrow or fetal liver cells from the prelymphomatous transgenic mice of both strains were transferred into irradiated normal C3H/HeJ mice, most of the recipients developed T lymphomas. Moreover, even when irradiated B6 mice received the hematopoietic stem cells from the prelymphomatous B6 transgenic mice, the incidence of T lymphoma increased up to 50%. These findings suggest that B6 and C3H/HeJ mice might provide the environment that supports the development or growth of B and T lymphomas, respectively, and that such an environment could be modified by irradiation of the mice.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504875      PMCID: PMC2189448          DOI: 10.1084/jem.170.3.711

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  47 in total

1.  Indirect induction of lymphomas in irradiated mice. I. Tumor incidence and morphology in mice bearing nonirradiated thymic grafts.

Authors:  H S KAPLAN; W H CARNES; M B BROWN; B B HIRSCH
Journal:  Cancer Res       Date:  1956-06       Impact factor: 12.701

2.  The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice.

Authors:  W Y Langdon; A W Harris; S Cory; J M Adams
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

Review 3.  Dissecting multistep tumorigenesis in transgenic mice.

Authors:  D Hanahan
Journal:  Annu Rev Genet       Date:  1988       Impact factor: 16.830

4.  Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice.

Authors:  W S Alexander; J W Schrader; J M Adams
Journal:  Mol Cell Biol       Date:  1987-04       Impact factor: 4.272

5.  Genetic control of B cell activation by bacterial lipopolysaccharide is mediated by multiple distinct genes or alleles.

Authors:  L M Glode; D L Rosenstreich
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

6.  Differential efficiencies of in vitro translation of mouse c-myc transcripts differing in the 5' untranslated region.

Authors:  A Darveau; J Pelletier; N Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

7.  The c-myc oncogene is translocated to the involved chromosome 12 in mouse plasmacytoma.

Authors:  J Erikson; D A Miller; O J Miller; P W Abcarian; R M Skurla; J F Mushinski; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

8.  Transcriptionally active c-myc oncogene is contained within NIARD, a DNA sequence associated with chromosome translocations in B-cell neoplasia.

Authors:  K B Marcu; L J Harris; L W Stanton; J Erikson; R Watt; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

Review 9.  Translocations among antibody genes in human cancer.

Authors:  P Leder; J Battey; G Lenoir; C Moulding; W Murphy; H Potter; T Stewart; R Taub
Journal:  Science       Date:  1983-11-18       Impact factor: 47.728

10.  Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives.

Authors:  D Eick; M Piechaczyk; B Henglein; J M Blanchard; B Traub; E Kofler; S Wiest; G M Lenoir; G W Bornkamm
Journal:  EMBO J       Date:  1985-12-30       Impact factor: 11.598

View more
  18 in total

Review 1.  Assessing new anti-tumour agents and strategies in oncogene transgenic mice.

Authors:  H Thomas; F Balkwill
Journal:  Cancer Metastasis Rev       Date:  1995-06       Impact factor: 9.264

2.  Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma.

Authors:  Katrina K Hoyer; Samuel W French; Devin E Turner; Mai T N Nguyen; Mathilde Renard; Cindy S Malone; Sonja Knoetig; Chen-Feng Qi; Thomas T Su; Hilde Cheroutre; Randolph Wall; David J Rawlings; Herbert C Morse; Michael A Teitell
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-14       Impact factor: 11.205

3.  Screening strategy to generate cell specific recombination: a case report with the RIP-Cre mice.

Authors:  Valeria Spinelli; Céline Martin; Emilie Dorchies; Emmanuelle Vallez; Hélène Dehondt; Mohamed-Sami Trabelsi; Anne Tailleux; Sandrine Caron; Bart Staels
Journal:  Transgenic Res       Date:  2015-06-20       Impact factor: 2.788

4.  Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice.

Authors:  Priti Chugh; Hittu Matta; Sandra Schamus; Sunny Zachariah; Arvind Kumar; James A Richardson; Alice L Smith; Preet M Chaudhary
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-24       Impact factor: 11.205

5.  Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice.

Authors:  Myung-Soo Kang; Hongxiang Lu; Teruhito Yasui; Arlene Sharpe; Henry Warren; Ellen Cahir-McFarland; Roderick Bronson; Siu Chun Hung; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-07       Impact factor: 11.205

6.  ATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cells.

Authors:  J Ludovic Croxford; Melissa Li Fang Tang; Meng Fei Pan; Caleb Weihao Huang; Neha Kamran; Cindy Meow Ling Phua; Wee Joo Chng; Siok Bian Ng; David H Raulet; Stephan Gasser
Journal:  Blood       Date:  2013-01-24       Impact factor: 22.113

7.  Deregulation of c-Myc Confers distinct survival requirements for memory B cells, plasma cells, and their progenitors.

Authors:  Sefat E Khuda; William M Loo; Siegfried Janz; Brian Van Ness; Loren D Erickson
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

8.  Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice.

Authors:  W Kulwichit; R H Edwards; E M Davenport; J F Baskar; V Godfrey; N Raab-Traub
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

9.  IgH enhancer deregulated expression of L-myc: abnormal T lymphocyte development and T cell lymphomagenesis.

Authors:  T Möröy; P Fisher; C Guidos; A Ma; K Zimmerman; A Tesfaye; R DePinho; I Weissman; F W Alt
Journal:  EMBO J       Date:  1990-11       Impact factor: 11.598

10.  Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein/ret fusion gene.

Authors:  T Iwamoto; M Takahashi; M Ito; K Hamatani; M Ohbayashi; W Wajjwalku; K Isobe; I Nakashima
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.